Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Al-DPS is an alkali-extractable polysaccharide derived from the mushroom *Dictyophora indusiata*, commonly known as the bamboo pith or veiled lady mushroom. Research indicates that Al-DPS possesses significant antihyperlipidemic, hepatoprotective, and antioxidant properties. In preclinical studies, it has been shown to improve serum and hepatic lipid profiles, reduce hepatic cell injury, and enhance the body's antioxidant status. Furthermore, Al-DPS demonstrates the ability to restrain blood sugar elevation, suggesting potential applications in the management of metabolic disorders such as hyperlipidemia and type 2 diabetes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Al-DPS.